REPCO

{
    key:"uid": string:"eayn4n6ilpoxarivjcul67b4536",
    key:"title": {
        key:"en": {
            key:"value": string:"What's right: effective double attack on cancer"
        }
    },
    key:"subtitle": {},
    key:"summary": {
        key:"en": {
            key:"value": string:"The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates."
        }
    },
    key:"content": {
        key:"en": {
            key:"value": string:"The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates."
        }
    },
    key:"titleTranslations": {
        key:"bg": {
            key:"value": string:"Какво е правилно: ефективна двойна атака срещу рака",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"Co je správné: účinný dvojitý útok na rakovinu",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"Was richtig ist: effektiver Doppelangriff auf Krebs",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"Τι είναι σωστό: αποτελεσματική διπλή επίθεση κατά του καρκίνου",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"What's right: effective double attack on cancer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"Lo que es correcto: ataque doble efectivo contra el cáncer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"Mikä on oikein: tehokas kaksoishyökkäys syöpää vastaan",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"Quelle est la bonne chose : attaque double efficace contre le cancer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"Što je ispravno: učinkoviti dvostruki napad na rak",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"Mi a helyes: hatékony kettős támadás a rák ellen",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"Cosa c'è di giusto: attacco doppio efficace contro il cancro",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"Wat is juist: effectieve dubbele aanval op kanker",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"Co jest słuszne: skuteczny podwójny atak na raka",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"O que é certo: ataque duplo eficaz ao câncer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"Ce este corect: atac dublu eficient asupra cancerului",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": string:"Что правильно: эффективная двойная атака на рак",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sk": {
            key:"value": string:"Čo je správne: účinný dvojitý útok na rakovinu",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": string:"Vad är rätt: effektiv dubbelattack mot cancer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"tr": {
            key:"value": string:"Kanser üzerinde etkili çift saldırı nedir",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": string:"Що правильно: ефективна подвійна атака на рак",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        }
    },
    key:"subtitleTranslations": {
        key:"bg": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"cs": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"de": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"el": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"en": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"es": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"fi": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"fr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"hr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"hu": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"it": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"nl": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"pl": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"pt": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"ro": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"summaryTranslations": {
        key:"bg": {
            key:"value": string:"<p>Групата по туморна имунна терапия и микроокръжение (TIME) от Люксембург е намерила начин да подобри имунната терапия при лечение на рак. Нейната двойна атака срещу туморите е показала, че значително ги свива и подобрява процентите на оцеляване.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"<p>Skupina lucemburských Tumor Immunotherapy and Microenvironment (TIME) našla způsob, jak zlepšit imunoterapii při léčbě rakoviny. Jejich dvojitý útok na nádory se ukázal jako významně zmenšující je a zlepšující míru přežití.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"<p>Die luxemburgische Tumorimmuntherapie- und Mikroumgebungsgruppe (TIME) hat einen Weg gefunden, die Immuntherapie bei der Behandlung von Krebs zu verbessern. Ihr doppelter Angriff auf Tumore hat gezeigt, dass sie signifikant schrumpfen und die Überlebensraten verbessern.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"<p>Η ομάδα Tumor Immunotherapy and Microenvironment (TIME) του Λουξεμβούργου έχει βρει έναν τρόπο να ενισχύσει την ανοσοθεραπεία κατά τη θεραπεία του καρκίνου. Η διπλή επίθεση τους στους όγκους έχει αποδειχθεί ότι τους συρρικνώνει σημαντικά και βελτιώνει τα ποσοστά επιβίωσης.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"<p>The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"<p>El grupo luxemburgués de Inmunoterapia Tumoral y Microambiente (TIME) ha encontrado una manera de mejorar la inmunoterapia al tratar el cáncer. Su doble ataque a los tumores ha demostrado reducirlos significativamente y mejorar las tasas de supervivencia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"<p>Luxemburgilainen Tuumori Immunoterapia ja Mikroympäristö (TIME) -ryhmä on löytänyt tavan parantaa immunoterapiaa syövän hoidossa. Heidän kaksoishyökkäyksensä tuumoreihin on osoittautunut merkittävästi kutistavaksi ja parantavaksi eloonjäämisasteita.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"<p>Le groupe luxembourgeois de l'immunothérapie tumorale et du microenvironnement (TIME) a trouvé un moyen d'améliorer l'immunothérapie lors du traitement du cancer. Leur double attaque sur les tumeurs a montré qu'elle les réduisait significativement et améliorait les taux de survie.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"<p>Grupa za imunoterapiju tumora i mikrookruženje (TIME) iz Luksemburga pronašla je način za poboljšanje imunoterapije prilikom liječenja raka. Njihov dvostruki napad na tumore pokazao je da značajno smanjuje tumore i poboljšava stope preživljavanja.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"<p>A luxemburgi Tumor Immunoterápiás és Mikrokörnyezet (TIME) csoport megtalálta a módját, hogy fokozza az immunterápiát a rák kezelésében. Kettős támadásuk a daganatok ellen jelentősen csökkentette azokat és javította a túlélési arányokat.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"<p>Il gruppo lussemburghese di Immunoterapia Tumorale e Microambiente (TIME) ha trovato un modo per migliorare l'immunoterapia nel trattamento del cancro. Il loro attacco doppio ai tumori ha dimostrato di ridurli significativamente e migliorare i tassi di sopravvivenza.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"<p>De Luxemburgse Tumor Immunotherapie en Microomgeving (TIME) groep heeft een manier gevonden om immunotherapie te verbeteren bij de behandeling van kanker. Hun dubbele aanval op tumoren heeft aangetoond dat ze aanzienlijk kunnen krimpen en de overlevingskansen kunnen verbeteren.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"<p>Grupa luksemburskiej immunoterapii nowotworowej i mikrośrodowiska (TIME) znalazła sposób na wzmocnienie immunoterapii w leczeniu raka. Ich podwójny atak na guzy wykazał, że znacznie je zmniejsza i poprawia wskaźniki przeżycia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"<p>O grupo luxemburguês de Imunoterapia Tumoral e Microambiente (TIME) encontrou uma maneira de aprimorar a imunoterapia ao tratar o câncer. Seu ataque duplo aos tumores mostrou reduzir significativamente seu tamanho e melhorar as taxas de sobrevivência.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"<p>Grupul luxemburghez de imunoterapie a tumorilor și microambient (TIME) a găsit o modalitate de a îmbunătăți imunoterapia în tratamentul cancerului. Atacul lor dublu asupra tumorilor a demonstrat că le micșorează semnificativ și îmbunătățește ratele de supraviețuire.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": string:"<p>Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla spôsob, ako zlepšiť imunoterapiu pri liečbe rakoviny. Ich dvojitý útok na nádory sa ukázal ako významne zmenšujúci a zlepšujúci miery prežitia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": string:"<p>Lüksemburg Tümör İmmünoterapisi ve Mikroçevre (TIME) grubu, kanser tedavisinde immünoterapiyi artırmanın bir yolunu bulmuştur. Tümörlere yönelik çift saldırıları, bunları önemli ölçüde küçültmüş ve hayatta kalma oranlarını artırmıştır.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"contentTranslations": {
        key:"bg": {
            key:"value": string:"<p>Групата по туморна имунна терапия и микросреда (TIME) от Люксембург е намерила начин да подобри имунната терапия при лечението на рак. Нейната двойна атака срещу туморите е показала, че значително ги свива и подобрява процентите на оцеляване.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"<p>Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla způsob, jak zlepšit imunoterapii při léčbě rakoviny. Jejich dvojitý útok na nádory se ukázal jako významně zmenšující je a zlepšující míru přežití.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"<p>Die luxemburgische Tumorimmuntherapie- und Mikroumgebungsgruppe (TIME) hat einen Weg gefunden, die Immuntherapie bei der Behandlung von Krebs zu verbessern. Ihr doppelter Angriff auf Tumore hat gezeigt, dass sie diese erheblich verkleinern und die Überlebensraten verbessern.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"<p>Η ομάδα Tumor Immunotherapy and Microenvironment (TIME) του Λουξεμβούργου έχει βρει έναν τρόπο να ενισχύσει την ανοσοθεραπεία κατά της καρκίνου. Η διπλή επίθεση τους στους όγκους έχει αποδειχθεί ότι τους συρρικνώνει σημαντικά και βελτιώνει τα ποσοστά επιβίωσης.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"<p>The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"<p>El grupo luxemburgués de Inmunoterapia Tumoral y Microambiente (TIME) ha encontrado una manera de mejorar la inmunoterapia al tratar el cáncer. Su doble ataque a los tumores ha demostrado reducirlos significativamente y mejorar las tasas de supervivencia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"<p>Luxemburgilainen Tuumori Immunoterapia ja Mikroympäristö (TIME) -ryhmä on löytänyt tavan parantaa immunoterapiaa syövän hoidossa. Heidän kaksoishyökkäyksensä tuumoreita vastaan on osoittautunut merkittävästi kutistavaksi ja parantavaksi eloonjäämisasteita.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"<p>Le groupe luxembourgeois d'immunothérapie tumorale et de microenvironnement (TIME) a trouvé un moyen d'améliorer l'immunothérapie lors du traitement du cancer. Leur double attaque sur les tumeurs a montré qu'elle les réduisait significativement et améliorait les taux de survie.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"<p>Luxembourgška skupina za imunoterapiju tumora i mikrookoliš (TIME) pronašla je način za poboljšanje imunoterapije prilikom liječenja raka. Njihov dvostruki napad na tumore pokazao je da značajno smanjuje tumore i poboljšava stope preživljavanja.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"<p>A luxemburgi Tumor Immunoterápiás és Mikrokörnyezet (TIME) csoport megtalálta a módját, hogy fokozza az immunterápiát a rák kezelésében. Kettős támadásuk a daganatok ellen jelentősen csökkentette azokat és javította a túlélési arányokat.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"<p>Il gruppo lussemburghese di Immunoterapia Tumorale e Microambiente (TIME) ha trovato un modo per migliorare l'immunoterapia nel trattamento del cancro. Il loro attacco doppio ai tumori ha dimostrato di ridurli significativamente e migliorare i tassi di sopravvivenza.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"<p>De Luxemburgse Tumor Immunotherapie en Micro-omgeving (TIME) groep heeft een manier gevonden om immunotherapie te verbeteren bij de behandeling van kanker. Hun dubbele aanval op tumoren heeft aangetoond dat ze aanzienlijk kunnen krimpen en de overlevingskansen kunnen verbeteren.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"<p>Grupa luksemburskiej immunoterapii nowotworowej i mikrośrodowiska (TIME) znalazła sposób na wzmocnienie immunoterapii w leczeniu raka. Ich podwójny atak na guzy wykazał, że znacznie je zmniejsza i poprawia wskaźniki przeżycia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"<p>O grupo de Imunoterapia Tumoral e Microambiente (TIME) de Luxemburgo encontrou uma maneira de aprimorar a imunoterapia ao tratar o câncer. Seu ataque duplo aos tumores mostrou reduzir significativamente seu tamanho e melhorar as taxas de sobrevivência.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"<p>Grupul luxemburghez de imunoterapie a tumorilor și microambient (TIME) a găsit o modalitate de a îmbunătăți imunoterapia în tratamentul cancerului. Atacul lor dublu asupra tumorilor a demonstrat că le micșorează semnificativ și îmbunătățește ratele de supraviețuire.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": string:"<p>Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla spôsob, ako zlepšiť imunoterapiu pri liečbe rakoviny. Ich dvojitý útok na nádory sa ukázal ako významne zmenšujúci ich a zlepšujúci miery prežitia.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": string:"<p>Lüksemburg Tümör İmmünoterapisi ve Mikroçevre (TIME) grubu, kanser tedavisinde immünoterapiyi artırmanın bir yolunu bulmuştur. Tümörlere yönelik çift saldırıları, bunları önemli ölçüde küçültmüş ve hayatta kalma oranlarını artırmıştır.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"revisionId": string:"vayyiloxizgtqrl2zjt7urh7htc",
    key:"pubDate": string:"2024-06-26T08:39:07",
    key:"contentUrl": {
        key:"en": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromContentUrl": boolean:true,
            key:"firstLanguage": boolean:true
        },
        key:"bg": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"cs": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"de": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"el": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"es": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"fi": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"fr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"hr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"hu": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"it": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"nl": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"pl": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"pt": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"ro": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"ru": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"sk": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"sr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"sv": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"tr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        },
        key:"uk": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-effective-double-attack-on-cancer",
            key:"fromLang": string:"en"
        }
    },
    key:"languageDetails": {
        key:"OriginalLanguages": number:1,
        key:"ContentItemLanguages": number:1,
        key:"ContentItemTranslations": number:21
    },
    key:"originalLanguages": {
        key:"language_codes": [
            string:"en"
        ]
    },
    key:"revision": {
        key:"dateModified": string:"2025-03-17T08:39:43.26",
        key:"__typename": string:"Revision"
    },
    key:"mediaAssets": {
        key:"nodes": [
            {
                key:"uid": string:"eayn4n6ilpowqrq45u2lne7m5ns",
                key:"mediaType": string:"audio/mpeg",
                key:"title": {
                    key:"en": {
                        key:"value": string:"What's right: effective double attack on cancer"
                    }
                },
                key:"duration": number:0,
                key:"files": {
                    key:"nodes": [
                        {
                            key:"contentUrl": string:"https://feeds.soundcloud.com/stream/1857031857-aracityradio-whats-right-effective-double-attack-on-cancer.mp3",
                            key:"mimeType": string:"audio/mpeg",
                            key:"__typename": string:"File"
                        }
                    ],
                    key:"__typename": string:"MediaAssetFilesByFileToMediaAssetBAndAManyToManyConnection"
                },
                key:"__typename": string:"MediaAsset"
            },
            {
                key:"uid": string:"eayyilowarvmarwn5ew4s5yogrs",
                key:"mediaType": string:"image/jpeg",
                key:"title": {
                    key:"en": {
                        key:"value": string:"What's right: effective double attack on cancer"
                    }
                },
                key:"duration": number:0,
                key:"files": {
                    key:"nodes": [
                        {
                            key:"contentUrl": string:"https://i1.sndcdn.com/artworks-CLz39a4myV0H9aDg-7m9b8A-t3000x3000.jpg",
                            key:"mimeType": string:"image/jpeg",
                            key:"__typename": string:"File"
                        }
                    ],
                    key:"__typename": string:"MediaAssetFilesByFileToMediaAssetBAndAManyToManyConnection"
                },
                key:"__typename": string:"MediaAsset"
            }
        ],
        key:"__typename": string:"ContentItemMediaAssetsByContentItemToMediaAssetAAndBManyToManyConnection"
    },
    key:"contentItemTranslations": {
        key:"nodes": [
            {
                key:"title": string:"Cosa c'è di giusto: attacco doppio efficace contro il cancro",
                key:"uid": string:"05e36c51-7823-4ebf-8bae-2be03c5d786a",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Il gruppo lussemburghese di Immunoterapia Tumorale e Microambiente (TIME) ha trovato un modo per migliorare l'immunoterapia nel trattamento del cancro. Il loro attacco doppio ai tumori ha dimostrato di ridurli significativamente e migliorare i tassi di sopravvivenza.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:44:13.722",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Il gruppo lussemburghese di Immunoterapia Tumorale e Microambiente (TIME) ha trovato un modo per migliorare l'immunoterapia nel trattamento del cancro. Il loro attacco doppio ai tumori ha dimostrato di ridurli significativamente e migliorare i tassi di sopravvivenza.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"it",
                key:"updatedAt": string:"2025-02-10T12:44:13.723",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Що правильно: ефективна подвійна атака на рак",
                key:"uid": string:"0a6459a8-908f-4dcc-bfb9-4079e428da36",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-12T11:56:16.383",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"uk",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Lo que es correcto: ataque doble efectivo contra el cáncer",
                key:"uid": string:"1b4fa5de-98ea-4de9-882d-e0fdcefe1bb0",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"El grupo luxemburgués de Inmunoterapia Tumoral y Microambiente (TIME) ha encontrado una manera de mejorar la inmunoterapia al tratar el cáncer. Su doble ataque a los tumores ha demostrado reducirlos significativamente y mejorar las tasas de supervivencia.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:36:31.151",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"El grupo luxemburgués de Inmunoterapia Tumoral y Microambiente (TIME) ha encontrado una manera de mejorar la inmunoterapia al tratar el cáncer. Su doble ataque a los tumores ha demostrado reducirlos significativamente y mejorar las tasas de supervivencia.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"es",
                key:"updatedAt": string:"2025-02-10T12:36:31.152",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Какво е правилно: ефективна двойна атака срещу рака",
                key:"uid": string:"1ca673d9-5aab-48bf-bb71-33d6b85633f0",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Групата по туморна имунна терапия и микросреда (TIME) от Люксембург е намерила начин да подобри имунната терапия при лечението на рак. Нейната двойна атака срещу туморите е показала, че значително ги свива и подобрява процентите на оцеляване.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:41:57.97",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Групата по туморна имунна терапия и микроокръжение (TIME) от Люксембург е намерила начин да подобри имунната терапия при лечение на рак. Нейната двойна атака срещу туморите е показала, че значително ги свива и подобрява процентите на оцеляване.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"bg",
                key:"updatedAt": string:"2025-02-10T12:41:57.971",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Что правильно: эффективная двойная атака на рак",
                key:"uid": string:"217bdac4-5fc4-42f2-b28d-bbbceecf7131",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-12T11:55:54.558",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"ru",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Mikä on oikein: tehokas kaksoishyökkäys syöpää vastaan",
                key:"uid": string:"3ea6dce8-2db4-4612-ba04-cdfcddd08de5",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Luxemburgilainen Tuumori Immunoterapia ja Mikroympäristö (TIME) -ryhmä on löytänyt tavan parantaa immunoterapiaa syövän hoidossa. Heidän kaksoishyökkäyksensä tuumoreita vastaan on osoittautunut merkittävästi kutistavaksi ja parantavaksi eloonjäämisasteita.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T13:31:23.524",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Luxemburgilainen Tuumori Immunoterapia ja Mikroympäristö (TIME) -ryhmä on löytänyt tavan parantaa immunoterapiaa syövän hoidossa. Heidän kaksoishyökkäyksensä tuumoreihin on osoittautunut merkittävästi kutistavaksi ja parantavaksi eloonjäämisasteita.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"fi",
                key:"updatedAt": string:"2025-02-10T13:32:43.262",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Τι είναι σωστό: αποτελεσματική διπλή επίθεση κατά του καρκίνου",
                key:"uid": string:"41c5dc79-31ea-4fb2-9a1f-85719f37f717",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Η ομάδα Tumor Immunotherapy and Microenvironment (TIME) του Λουξεμβούργου έχει βρει έναν τρόπο να ενισχύσει την ανοσοθεραπεία κατά της καρκίνου. Η διπλή επίθεση τους στους όγκους έχει αποδειχθεί ότι τους συρρικνώνει σημαντικά και βελτιώνει τα ποσοστά επιβίωσης.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T13:02:27.658",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Η ομάδα Tumor Immunotherapy and Microenvironment (TIME) του Λουξεμβούργου έχει βρει έναν τρόπο να ενισχύσει την ανοσοθεραπεία κατά τη θεραπεία του καρκίνου. Η διπλή επίθεση τους στους όγκους έχει αποδειχθεί ότι τους συρρικνώνει σημαντικά και βελτιώνει τα ποσοστά επιβίωσης.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"el",
                key:"updatedAt": string:"2025-02-10T13:02:38.135",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Čo je správne: účinný dvojitý útok na rakovinu",
                key:"uid": string:"77153179-b366-4887-b056-4bd0cbba10ac",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla spôsob, ako zlepšiť imunoterapiu pri liečbe rakoviny. Ich dvojitý útok na nádory sa ukázal ako významne zmenšujúci ich a zlepšujúci miery prežitia.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:35:45.391",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla spôsob, ako zlepšiť imunoterapiu pri liečbe rakoviny. Ich dvojitý útok na nádory sa ukázal ako významne zmenšujúci a zlepšujúci miery prežitia.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sk",
                key:"updatedAt": string:"2025-02-10T12:35:45.392",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Co jest słuszne: skuteczny podwójny atak na raka",
                key:"uid": string:"7e46f168-0382-4c3d-8178-c9b7535522c8",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Grupa luksemburskiej immunoterapii nowotworowej i mikrośrodowiska (TIME) znalazła sposób na wzmocnienie immunoterapii w leczeniu raka. Ich podwójny atak na guzy wykazał, że znacznie je zmniejsza i poprawia wskaźniki przeżycia.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T13:22:33.682",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Grupa luksemburskiej immunoterapii nowotworowej i mikrośrodowiska (TIME) znalazła sposób na wzmocnienie immunoterapii w leczeniu raka. Ich podwójny atak na guzy wykazał, że znacznie je zmniejsza i poprawia wskaźniki przeżycia.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"pl",
                key:"updatedAt": string:"2025-02-10T13:22:44.14",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Quelle est la bonne chose : attaque double efficace contre le cancer",
                key:"uid": string:"8ad2c124-e3d5-484b-a1eb-3a0ab639e3e2",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Le groupe luxembourgeois d'immunothérapie tumorale et de microenvironnement (TIME) a trouvé un moyen d'améliorer l'immunothérapie lors du traitement du cancer. Leur double attaque sur les tumeurs a montré qu'elle les réduisait significativement et améliorait les taux de survie.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:42:44.704",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Le groupe luxembourgeois de l'immunothérapie tumorale et du microenvironnement (TIME) a trouvé un moyen d'améliorer l'immunothérapie lors du traitement du cancer. Leur double attaque sur les tumeurs a montré qu'elle les réduisait significativement et améliorait les taux de survie.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"fr",
                key:"updatedAt": string:"2025-02-10T12:42:44.705",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Co je správné: účinný dvojitý útok na rakovinu",
                key:"uid": string:"9d27ad50-84ce-41c2-86b7-25cacfab8503",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Luxemburská skupina Tumor Immunotherapy and Microenvironment (TIME) našla způsob, jak zlepšit imunoterapii při léčbě rakoviny. Jejich dvojitý útok na nádory se ukázal jako významně zmenšující je a zlepšující míru přežití.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T13:12:01.569",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Skupina lucemburských Tumor Immunotherapy and Microenvironment (TIME) našla způsob, jak zlepšit imunoterapii při léčbě rakoviny. Jejich dvojitý útok na nádory se ukázal jako významně zmenšující je a zlepšující míru přežití.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"cs",
                key:"updatedAt": string:"2025-02-10T13:12:11.651",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Mi a helyes: hatékony kettős támadás a rák ellen",
                key:"uid": string:"a02b5281-e032-4849-9a65-fe7dea30f556",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"A luxemburgi Tumor Immunoterápiás és Mikrokörnyezet (TIME) csoport megtalálta a módját, hogy fokozza az immunterápiát a rák kezelésében. Kettős támadásuk a daganatok ellen jelentősen csökkentette azokat és javította a túlélési arányokat.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:30:54.969",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"A luxemburgi Tumor Immunoterápiás és Mikrokörnyezet (TIME) csoport megtalálta a módját, hogy fokozza az immunterápiát a rák kezelésében. Kettős támadásuk a daganatok ellen jelentősen csökkentette azokat és javította a túlélési arányokat.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"hu",
                key:"updatedAt": string:"2025-02-10T12:31:25.955",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Ce este corect: atac dublu eficient asupra cancerului",
                key:"uid": string:"a53cc0f8-a01b-423a-9a26-e656367c0352",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Grupul luxemburghez de imunoterapie a tumorilor și microambient (TIME) a găsit o modalitate de a îmbunătăți imunoterapia în tratamentul cancerului. Atacul lor dublu asupra tumorilor a demonstrat că le micșorează semnificativ și îmbunătățește ratele de supraviețuire.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T13:08:14.915",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Grupul luxemburghez de imunoterapie a tumorilor și microambient (TIME) a găsit o modalitate de a îmbunătăți imunoterapia în tratamentul cancerului. Atacul lor dublu asupra tumorilor a demonstrat că le micșorează semnificativ și îmbunătățește ratele de supraviețuire.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"ro",
                key:"updatedAt": string:"2025-02-10T13:08:26.146",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Što je ispravno: učinkoviti dvostruki napad na rak",
                key:"uid": string:"adf3cf0b-73ef-442e-ad6e-3dd015957f36",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Luxembourgška skupina za imunoterapiju tumora i mikrookoliš (TIME) pronašla je način za poboljšanje imunoterapije prilikom liječenja raka. Njihov dvostruki napad na tumore pokazao je da značajno smanjuje tumore i poboljšava stope preživljavanja.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:35:10.488",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Grupa za imunoterapiju tumora i mikrookruženje (TIME) iz Luksemburga pronašla je način za poboljšanje imunoterapije prilikom liječenja raka. Njihov dvostruki napad na tumore pokazao je da značajno smanjuje tumore i poboljšava stope preživljavanja.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"hr",
                key:"updatedAt": string:"2025-02-10T12:35:10.489",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Kanser üzerinde etkili çift saldırı nedir",
                key:"uid": string:"b36171d7-db9f-459e-a604-2219ed9d610d",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Lüksemburg Tümör İmmünoterapisi ve Mikroçevre (TIME) grubu, kanser tedavisinde immünoterapiyi artırmanın bir yolunu bulmuştur. Tümörlere yönelik çift saldırıları, bunları önemli ölçüde küçültmüş ve hayatta kalma oranlarını artırmıştır.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:58:03.754",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Lüksemburg Tümör İmmünoterapisi ve Mikroçevre (TIME) grubu, kanser tedavisinde immünoterapiyi artırmanın bir yolunu bulmuştur. Tümörlere yönelik çift saldırıları, bunları önemli ölçüde küçültmüş ve hayatta kalma oranlarını artırmıştır.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"tr",
                key:"updatedAt": string:"2025-02-10T12:58:03.755",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"What's right: effective double attack on cancer",
                key:"uid": string:"bdcdd9d1-2566-44a8-8fed-dab8a7a4e9ac",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-01-24T10:47:30.318",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"en",
                key:"updatedAt": string:"2025-02-10T12:38:35.925",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Wat is juist: effectieve dubbele aanval op kanker",
                key:"uid": string:"c6908bc3-0e24-44cc-a0a8-0ae13efa0c45",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"De Luxemburgse Tumor Immunotherapie en Micro-omgeving (TIME) groep heeft een manier gevonden om immunotherapie te verbeteren bij de behandeling van kanker. Hun dubbele aanval op tumoren heeft aangetoond dat ze aanzienlijk kunnen krimpen en de overlevingskansen kunnen verbeteren.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:42:57.674",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"De Luxemburgse Tumor Immunotherapie en Microomgeving (TIME) groep heeft een manier gevonden om immunotherapie te verbeteren bij de behandeling van kanker. Hun dubbele aanval op tumoren heeft aangetoond dat ze aanzienlijk kunnen krimpen en de overlevingskansen kunnen verbeteren.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"nl",
                key:"updatedAt": string:"2025-02-10T12:43:03.879",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"O que é certo: ataque duplo eficaz ao câncer",
                key:"uid": string:"cc2ceb81-6032-4dc1-886a-f79193ab3b26",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"O grupo de Imunoterapia Tumoral e Microambiente (TIME) de Luxemburgo encontrou uma maneira de aprimorar a imunoterapia ao tratar o câncer. Seu ataque duplo aos tumores mostrou reduzir significativamente seu tamanho e melhorar as taxas de sobrevivência.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:38:43.461",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"O grupo luxemburguês de Imunoterapia Tumoral e Microambiente (TIME) encontrou uma maneira de aprimorar a imunoterapia ao tratar o câncer. Seu ataque duplo aos tumores mostrou reduzir significativamente seu tamanho e melhorar as taxas de sobrevivência.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"pt",
                key:"updatedAt": string:"2025-02-10T12:39:09.755",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Vad är rätt: effektiv dubbelattack mot cancer",
                key:"uid": string:"d06d91c0-23f6-4760-9aef-131d09f567bc",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-12T11:55:38.221",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sv",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Was richtig ist: effektiver Doppelangriff auf Krebs",
                key:"uid": string:"d61b5e09-a6f1-43c8-bb01-5ed514b45760",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Die luxemburgische Tumorimmuntherapie- und Mikroumgebungsgruppe (TIME) hat einen Weg gefunden, die Immuntherapie bei der Behandlung von Krebs zu verbessern. Ihr doppelter Angriff auf Tumore hat gezeigt, dass sie diese erheblich verkleinern und die Überlebensraten verbessern.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-10T12:54:43.762",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": string:"Die luxemburgische Tumorimmuntherapie- und Mikroumgebungsgruppe (TIME) hat einen Weg gefunden, die Immuntherapie bei der Behandlung von Krebs zu verbessern. Ihr doppelter Angriff auf Tumore hat gezeigt, dass sie signifikant schrumpfen und die Überlebensraten verbessern.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"de",
                key:"updatedAt": string:"2025-02-10T12:54:53.183",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Šta je ispravno: efikasni dvostruki napad na rak",
                key:"uid": string:"f6bd647a-8276-4015-84fd-cd3f77bba44c",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayn4n6ilpoxarivjcul67b4536",
                key:"createdAt": string:"2025-02-17T07:24:47.911",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayn4n6jud5zarcrbgs3l4glz5m",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sr",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            }
        ],
        key:"totalCount": number:21,
        key:"__typename": string:"ContentItemTranslationsConnection"
    },
    key:"__typename": string:"ContentItem"
}